Medindia

X

Elekta Sees Record Attendance and Record Number of Submitted Abstracts at International Leksell Gamma Knife(R) Society Meeting in Quebec, Canada

Thursday, May 22, 2008 General News J E 4
Advertisement
STOCKHOLM, Sweden, May 21 At the 14th InternationalLeksell Gamma Knife(R) Society Meeting on May 18-22, over 500 participantsincluding neurosurgeons, radiation oncologists and other medical specialistsusing Leksell Gamma Knife for treatment of tumors and other brain disordersconvened at the historic Chateau Frontenac Hotel in Quebec, Canada. During themeeting, 260 oral and poster presentations covered treatment of malignant andbenign brain tumors, functional neurosurgery, imaging and biology as well asphysics and technology. Wednesday, May 21, the prestigious Pioneers inRadiosurgery Award was presented to John Flickinger, M.D., Professor ofRadiation Oncology and Neurological Surgery at the University of Pittsburghfor his early pioneering work on prediction of complications following GammaKnife(R) surgery.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGO )

The Leksell Gamma Knife Society was established in 1989 to provide a forumfor Gamma Knife users to share information, experiences, clinical techniquesand advanced scientific research in their quest to non-invasively treat anexpanding number of brain disorders. The meetings, which are held biannually,result in a large number of clinical publications, in recent years publishedas a supplement to Journal of Neurosurgery. The Society plays an importantrole in increasing the visibility and acceptance of Gamma Knife surgery in theworldwide medical community, among healthcare providers and among patients.The open sharing of results and experiences allows all Gamma Knife users tomaintain leadership in the field of intracranial radiosurgery, based on themost recent clinical advancements.

The 14th meeting in Quebec is held with the theme, "Je me Souviens ... "("I Remember ... "), which is the motto of Quebec. The theme connects thecelebration of Quebec 400 year long history with the 40 year long history ofGamma Knife surgery.

Pioneers in Radiosurgery Award

John Flickinger, M.D., is Professor of Radiation Oncology and NeurologicalSurgery at the University of Pittsburgh, and recipient of this year's LeksellGamma Knife Society Pioneers in Radiosurgery Award. Bestowed upon researcherswho have consistently pioneered new approaches and methods that enhance theresults of Gamma Knife surgery, Dr. Flickinger pioneered the "integratedlogistic formula" for prediction of complications in his landmark paper of1989. He has since conducted numerous studies on dose effects of Gamma Knifesurgery in a diverse group of pathologies.

Previous recipients of the Pioneers in Radiosurgery Award include StevenRasmussen, M.D., and Richard Marsland, R.N., of Butler Hospital, Rhode Island;and Christer Lindquist, M.D., of Cromwell Hospital, London, UK. They wereawarded for their work in the treatment of Obsessive Compulsive Disorder usingGamma Knife surgery.

Leksell Gamma Knife(R) Perfexion(TM)

During the Society meeting, a special lecture was held by Professor JeanRegis, from University Hospital La Timone in Marseille, France. ProfessorRegis and his team has now treated over 800 patients with Leksell Gamma KnifePerfexion, a new, completely revised and fully robotized Gamma Knife and themost advanced technology for radiosurgery available on the market. Thepresentation by Professor Regis highlighted the unique dose shapingcapabilities of Leksell Gamma Knife Perfexion, treating a broader range oftargets, much faster and more efficiently than ever before.

Now in clinical use in more than 30 locations worldwide, Leksell GammaKnife Perfexion combines the proven precision of the revolutionary LeksellGamma Knife with a 300 percent expansion in clinical reach to treat a widerrange of targets faster and more efficiently than ever before. The system'sunique geometric and dosimetric design simultaneously administers hundreds ofbeams of low-intensity radiation that converge to
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
QuatRx Pharmaceuticals Announces Presentation of F...
S
Aton Pharma Announces Distribution Partnership in ...